Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Mar;63(3):1070–1075. doi: 10.1128/iai.63.3.1070-1075.1995

Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans.

M E Wilson 1, P M Bronson 1, R G Hamilton 1
PMCID: PMC173111  PMID: 7868229

Abstract

Sera from patients with localized juvenile periodontitis (LJP) often contain markedly elevated levels of immunoglobulin G2 (IgG2) antibodies reactive to cell envelope constituents of Actinobacillus actinomycetemcomitans. The objective of this study was to determine if these IgG2 antibodies are capable of supporting phagocytosis and killing of A. actinomycetemcomitans by human neutrophils. Polyclonal IgG2 antibodies were prepared from high-titer LJP serum by affinity chromatography, yielding a preparation which was > 99% subclass restricted and retained immunoreactivity to A. actinomycetemcomitans antigens. Affinity-purified IgG2 antibodies were evaluated by an in vitro opsonophagocytic assay that employed neutrophils obtained from donors who were homozygous for the H131 allotype of Fc gamma receptor type IIa (CD32), which efficiently binds human IgG2 antibodies. Affinity-purified IgG2 antibodies from LJP serum but not from sera of periodontally healthy individuals promoted phagocytosis and killing of A. actinomycetemcomitans. The expression of IgG2-dependent opsonic activity required the presence of complement. Incubation of A. actinomycetemcomitans with neutrophils in the presence of an optimal concentration of LJP IgG2 (50 micrograms/ml) and 5% hypogammaglobulinemic serum (as a complement source) resulted in a > 1 log10 reduction in bacterial viability within 30 min. The opsonic activity of IgG2 antibodies was found to be comparable to that observed with affinity-purified IgG1 antibodies. Moreover, IgG1 antibodies interacted synergistically with IgG2 antibodies in promoting opsonophagocytosis of A. actinomycetemcomitans. The results of this study indicate that LJP serum contains IgG2 antibodies which, when employed in conjunction with neutrophils that express Fc gamma receptors capable of recognizing this subclass, are opsonic for A. actinomycetemcomitans.

Full Text

The Full Text of this article is available as a PDF (220.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AboT, Tilden A. B., Balch C. M., Kumagai K., Troup G. M., Cooper M. D. Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule. J Exp Med. 1984 Jul 1;160(1):303–309. doi: 10.1084/jem.160.1.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amir J., Scott M. G., Nahm M. H., Granoff D. M. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J Infect Dis. 1990 Jul;162(1):163–171. doi: 10.1093/infdis/162.1.163. [DOI] [PubMed] [Google Scholar]
  3. Anderson C. L., Ryan D. H., Looney R. J., Leary P. C. Structural polymorphism of the human monocyte 40 kilodalton Fc receptor for IgG. J Immunol. 1987 Apr 1;138(7):2254–2256. [PubMed] [Google Scholar]
  4. Baker P. J., Wilson M. E. Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. Oral Microbiol Immunol. 1989 Jun;4(2):98–105. doi: 10.1111/j.1399-302x.1989.tb00106.x. [DOI] [PubMed] [Google Scholar]
  5. Bredius R. G., Driedijk P. C., Schouten M. F., Weening R. S., Out T. A. Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. Infect Immun. 1992 Nov;60(11):4838–4847. doi: 10.1128/iai.60.11.4838-4847.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bredius R. G., de Vries C. E., Troelstra A., van Alphen L., Weening R. S., van de Winkel J. G., Out T. A. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. J Immunol. 1993 Aug 1;151(3):1463–1472. [PubMed] [Google Scholar]
  7. Brüggemann M., Williams G. T., Bindon C. I., Clark M. R., Walker M. R., Jefferis R., Waldmann H., Neuberger M. S. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med. 1987 Nov 1;166(5):1351–1361. doi: 10.1084/jem.166.5.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ebersole J. L. Systemic humoral immune responses in periodontal disease. Crit Rev Oral Biol Med. 1990;1(4):283–331. doi: 10.1177/10454411900010040601. [DOI] [PubMed] [Google Scholar]
  9. Fauci A. S., Frank M. M., Johnson J. S. The relationship between antibody affinity and the efficiency of complement fixation. J Immunol. 1970 Jul;105(1):215–220. [PubMed] [Google Scholar]
  10. Fijen C. A., Bredius R. G., Kuijper E. J. Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med. 1993 Oct 1;119(7 Pt 1):636–636. doi: 10.7326/0003-4819-119-7_part_1-199310010-00026. [DOI] [PubMed] [Google Scholar]
  11. Gunsolley J. C., Burmeister J. A., Tew J. G., Best A. M., Ranney R. R. Relationship of serum antibody to attachment level patterns in young adults with juvenile periodontitis or generalized severe periodontitis. J Periodontol. 1987 May;58(5):314–320. doi: 10.1902/jop.1987.58.5.314. [DOI] [PubMed] [Google Scholar]
  12. Gunsolley J. C., Tew J. G., Gooss C. M., Burmeister J. A., Schenkein H. A. Effects of race and periodontal status on antibody reactive with Actinobacillus actinomycetemcomitans strain Y4. J Periodontal Res. 1988 Sep;23(5):303–307. doi: 10.1111/j.1600-0765.1988.tb01421.x. [DOI] [PubMed] [Google Scholar]
  13. Hamilton R. G., Wilson R. W., Spillman T., Roebber M. Monoclonal antibody-based immunoenzymetric assays for quantification of human IgG and its four subclasses. J Immunoassay. 1988;9(3-4):275–296. doi: 10.1080/01971528808053217. [DOI] [PubMed] [Google Scholar]
  14. Hammarström L., Smith C. I. IgG subclass changes in response to vaccination. Monogr Allergy. 1986;19:241–252. [PubMed] [Google Scholar]
  15. Hammarström L., Smith C. I. IgG subclasses in bacterial infections. Monogr Allergy. 1986;19:122–133. [PubMed] [Google Scholar]
  16. Jefferis R., Kumararatne D. S. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol. 1990 Sep;81(3):357–367. doi: 10.1111/j.1365-2249.1990.tb05339.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lu H., Califano J. V., Schenkein H. A., Tew J. G. Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actinomycetemcomitans serotype b. Infect Immun. 1993 Jun;61(6):2400–2407. doi: 10.1128/iai.61.6.2400-2407.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lu H., Wang M., Gunsolley J. C., Schenkein H. A., Tew J. G. Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals. Infect Immun. 1994 May;62(5):1677–1682. doi: 10.1128/iai.62.5.1677-1682.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Musser J. M., Kroll J. S., Granoff D. M., Moxon E. R., Brodeur B. R., Campos J., Dabernat H., Frederiksen W., Hamel J., Hammond G. Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis. 1990 Jan-Feb;12(1):75–111. doi: 10.1093/clinids/12.1.75. [DOI] [PubMed] [Google Scholar]
  20. Osborne J. M., Chacko G. W., Brandt J. T., Anderson C. L. Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIA determined with allele specific oligonucleotide probes. J Immunol Methods. 1994 Aug 1;173(2):207–217. doi: 10.1016/0022-1759(94)90299-2. [DOI] [PubMed] [Google Scholar]
  21. Persson M. A., Brown S. E., Steward M. W., Hammarström L., Smith C. I., Howard C. R., Wahl M., Rynnel-Dagö B., Lefranc G., Carbonara A. O. IgG subclass-associated affinity differences of specific antibodies in humans. J Immunol. 1988 Jun 1;140(11):3875–3879. [PubMed] [Google Scholar]
  22. Ranney R. R., Yanni N. R., Burmeister J. A., Tew J. G. Relationship between attachment loss and precipitating serum antibody to Actinobacillus actinomycetemcomitans in adolescents and young adults having severe periodontal destruction. J Periodontol. 1982 Jan;53(1):1–7. doi: 10.1902/jop.1982.53.1.1. [DOI] [PubMed] [Google Scholar]
  23. Salmon J. E., Edberg J. C., Brogle N. L., Kimberly R. P. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest. 1992 Apr;89(4):1274–1281. doi: 10.1172/JCI115712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Smith T. F. IgG subclasses. Adv Pediatr. 1992;39:101–126. [PubMed] [Google Scholar]
  25. Tax W. J., Willems H. W., Reekers P. P., Capel P. J., Koene R. A. Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells. Nature. 1983 Aug 4;304(5925):445–447. doi: 10.1038/304445a0. [DOI] [PubMed] [Google Scholar]
  26. Tsai C. C., McArthur W. P., Baehni P. C., Evian C., Genco R. J., Taichman N. S. Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol. 1981 Aug;8(4):338–348. doi: 10.1111/j.1600-051x.1981.tb02043.x. [DOI] [PubMed] [Google Scholar]
  27. Warmerdam P. A., Parren P. W., Vlug A., Aarden L. A., van de Winkel J. G., Capel P. J. Polymorphism of the human Fc gamma receptor II (CD32): molecular basis and functional aspects. Immunobiology. 1992 Aug;185(2-4):175–182. doi: 10.1016/s0171-2985(11)80639-x. [DOI] [PubMed] [Google Scholar]
  28. Warmerdam P. A., van de Winkel J. G., Gosselin E. J., Capel P. J. Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med. 1990 Jul 1;172(1):19–25. doi: 10.1084/jem.172.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Warmerdam P. A., van de Winkel J. G., Vlug A., Westerdaal N. A., Capel P. J. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol. 1991 Aug 15;147(4):1338–1343. [PubMed] [Google Scholar]
  30. Watanabe H., Marsh P. D., Ivanyi L. Antigens of Actinobacillus actinomycetemcomitans identified by immunoblotting with sera from patients with localized human juvenile periodontitis and generalized severe periodontitis. Arch Oral Biol. 1989;34(8):649–656. doi: 10.1016/0003-9969(89)90020-4. [DOI] [PubMed] [Google Scholar]
  31. Wilson M. E., Hamilton R. G. Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans. Infect Immun. 1995 Mar;63(3):1062–1069. doi: 10.1128/iai.63.3.1062-1069.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wilson M. E., Hamilton R. G. Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide. Infect Immun. 1992 May;60(5):1806–1812. doi: 10.1128/iai.60.5.1806-1812.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wilson M. E. IgG antibody response of localized juvenile periodontitis patients to the 29 kilodalton outer membrane protein of Actinobacillus actinomycetemcomitans. J Periodontol. 1991 Mar;62(3):211–218. doi: 10.1902/jop.1991.62.3.211. [DOI] [PubMed] [Google Scholar]
  34. Wilson M. E., Schifferle R. E. Evidence that the serotype b antigenic determinant of Actinobacillus actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide. Infect Immun. 1991 Apr;59(4):1544–1551. doi: 10.1128/iai.59.4.1544-1551.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zambon J. J. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol. 1985 Jan;12(1):1–20. doi: 10.1111/j.1600-051x.1985.tb01348.x. [DOI] [PubMed] [Google Scholar]
  36. van de Winkel J. G., Anderson C. L. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol. 1991 May;49(5):511–524. doi: 10.1002/jlb.49.5.511. [DOI] [PubMed] [Google Scholar]
  37. van de Winkel J. G., Capel P. J. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today. 1993 May;14(5):215–221. doi: 10.1016/0167-5699(93)90166-I. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES